Clinical trial
A Randomized Study of the Safety and Efficacy of FG-2216 in Subjects With Renal…
NCT00456053 · Kyntra Bio, Industry · Completed
Key facts
| NCT number | NCT00456053 |
|---|---|
| Title | A Randomized Study of the Safety and Efficacy of FG-2216 in Subjects With Renal Anemia Not Requiring Dialysis and Not Receiving Recombinant Human Erythropoietin |
| Official title | A Randomized Study of the Safety and Efficacy of FG-2216 in Subjects With Renal Anemia Not Requiring Dialysis and Not Receiving Recombinant Human Erythropoietin |
| Lead sponsor | Kyntra Bio, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Renal Anemia |
| Intervention type | Drug |
| Interventions | FG2216 |
| Enrollment | 145 |
| Start date | Dec 1, 2005 |
| Completion | Jul 1, 2007 |
| First posted | Apr 4, 2007 |
| Last update posted | Nov 6, 2007 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: